XTX Topco’s Bionano Genomics BNGO Stock Holding History

XTX Topco’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.4K	Buy	+16,295	New	+$19.6K	﹤0.01%	3923
2025 Q1	–	Sell	-2,621	Closed	-$45.4K	–	2442
2024 Q4	$45.4K	Buy	+2,621	New	+$44.8K	﹤0.01%	1912
2024 Q2	–	Sell	-1,614	Closed	-$108K	–	1894
2024 Q1	$108K	Buy	+1,614	New	+$120K	0.01%	1349
2023 Q3	–	Sell	-136	Closed	-$49.7K	–	1579
2023 Q2	$49.7K	Buy	+136	New	+$61.4K	0.01%	1236
2023 Q1	–	Sell	-146	Closed	-$128K	–	1287
2022 Q4	$128K	Buy	+146	New	+$184K	0.03%	954
2021 Q3	–	Sell	-17	Closed	-$76K	–	706
2021 Q2	$76K	Buy	+17	New	+$67.1K	0.03%	689

Other funds holding BNGO

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

CAM

Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

EGM

Engineers Gate Manager New York $7.71B AUM 24.88% 1-Year Est. Return

XTX Topco's BNGO Position: Q2 2026 in Review

XTX Topco opened a new position in Bionano Genomics (BNGO) in Q2 2026: 16,295 shares worth $18.4K. The stake represents ﹤0.01% of the portfolio and ranks #3923 among its holdings. This is a return to the name: XTX Topco previously reported a position in BNGO as recently as Q4 2024.

XTX Topco first reported a position in BNGO in Q2 2021 and has held it in 6 quarters since. The position peaked at $128K in Q4 2022. 34 funds tracked by Wall St. Rank hold BNGO as of Q2 2026.

XTX Topco held 16,295 shares of Bionano Genomics worth $18.4K as of Q2 2026.
Bionano Genomics was a new XTX Topco position in Q2 2026.
Bionano Genomics made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3923 holding.
XTX Topco first reported a position in Bionano Genomics in Q2 2021 and has held it in 6 quarters since.
XTX Topco's Bionano Genomics position peaked at $128K in Q4 2022.
34 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.